CTNND1 and hepatocellular carcinoma: Recent evidence indicates that miR-103 derived from hepatoma cells could be transmitted to endothelial cells via EVs, which then inhibits the expression of VE-cadherin, p120-catenin (p120) and ZO-1 to attenuate the integrity of endothelial junctions and induce vascular leakiness [149].